3Ps of Insulin & T2 2006 3Ps of Insulin & T2 2006
3Ps of Insulin & T2 2006
Home Registration Agenda Hotel Logistics Contact
3Ps of Insulin & T2 2006
Click Here to download report.*

*This file is in PDF format, which requires the free Adobe Acrobat Reader for viewing.

The National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK) and the Food and Drug Administration (FDA) will be facilitating a workshop entitled "Predictors, Pathogenesis, and Prevention of Insulin Resistance and Type 2 Diabetes." The meeting will be held October 4-5, 2006, in the Natcher Conference Center on the NIH campus in Bethesda, MD. The goals of the meeting are to:
  • Share the latest information about predictors for type 2 diabetes and discuss obstacles and solutions for widespread use of a predictor system.
  • Explore potential common etiology pathways for development of syndromes associated with insulin resistance, obesity, and type 2 diabetes.
  • Reexamine the adequacy of the current data to support an indication to treat for prevention of diabetes.
The key questions to be answered by the end of the meeting are:
  • What important, unanswered issue can only be answered through a large clinical trial?
  • Is there any area that is not being explored that could benefit from targeted funding opportunities?
  • What would you consider sufficient evidence to justify a pharmacological treatment to prevent or delay the onset of type 2 diabetes?



3Ps of Insulin & T2 2006

  Return to NIDDK Homepage.
   This page last updated 7/31/2006.